88 related articles for article (PubMed ID: 25964147)
1. Anti-proliferative and pro-apoptotic effects of lichen-derived compound protolichesterinic acid are not mediated by its lipoxygenase-inhibitory activity.
Bessadóttir M; Eiríksson FF; Becker S; Ögmundsdóttir MH; Ómarsdóttir S; Thorsteinsdóttir M; Ögmundsdóttir HM
Prostaglandins Leukot Essent Fatty Acids; 2015 Jul; 98():39-47. PubMed ID: 25964147
[TBL] [Abstract][Full Text] [Related]
2. Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase, cell signalling and drug response in breast cancer cells.
Bessadóttir M; Skúladóttir EÁ; Gowan S; Eccles S; Ögmundsdóttir S; Ogmundsdóttir HM
Phytomedicine; 2014 Oct; 21(12):1717-24. PubMed ID: 25442282
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes.
Ogmundsdóttir HM; Zoëga GM; Gissurarson SR; Ingólfsdóttir K
J Pharm Pharmacol; 1998 Jan; 50(1):107-15. PubMed ID: 9504441
[TBL] [Abstract][Full Text] [Related]
4. Protolichesterinic Acid, Isolated from the Lichen Cetraria islandica, Reduces LRRC8A Expression and Volume-Sensitive Release of Organic Osmolytes in Human Lung Epithelial Cancer Cells.
Thorsteinsdottir UA; Thorsteinsdottir M; Lambert IH
Phytother Res; 2016 Jan; 30(1):97-104. PubMed ID: 26549524
[TBL] [Abstract][Full Text] [Related]
5. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
Ding XZ; Iversen P; Cluck MW; Knezetic JA; Adrian TE
Biochem Biophys Res Commun; 1999 Jul; 261(1):218-23. PubMed ID: 10405349
[TBL] [Abstract][Full Text] [Related]
6. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
[TBL] [Abstract][Full Text] [Related]
7. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
[TBL] [Abstract][Full Text] [Related]
8. The Anti-Proliferative Lichen-Compound Protolichesterinic Acid Inhibits Oxidative Phosphorylation and Is Processed via the Mercapturic Pathway in Cancer Cells.
Jóhannsson F; Cherek P; Xu M; Rolfsson Ó; Ögmundsdóttir HM
Planta Med; 2022 Sep; 88(11):891-898. PubMed ID: 34521132
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro.
Haraldsdóttir S; Guolaugsdóttir E; Ingólfsdóttir K; Ogmundsdóttir HM
Planta Med; 2004 Nov; 70(11):1098-100. PubMed ID: 15549672
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study.
Brisdelli F; Perilli M; Sellitri D; Piovano M; Garbarino JA; Nicoletti M; Bozzi A; Amicosante G; Celenza G
Phytother Res; 2013 Mar; 27(3):431-7. PubMed ID: 22628260
[TBL] [Abstract][Full Text] [Related]
11. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells.
Ding XZ; Kuszynski CA; El-Metwally TH; Adrian TE
Biochem Biophys Res Commun; 1999 Dec; 266(2):392-9. PubMed ID: 10600514
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets.
Bucar F; Schneider I; Ogmundsdóttir H; Ingólfsdóttir K
Phytomedicine; 2004 Nov; 11(7-8):602-6. PubMed ID: 15636173
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways.
Agarwal S; Achari C; Praveen D; Roy KR; Reddy GV; Reddanna P
Exp Dermatol; 2009 Nov; 18(11):939-46. PubMed ID: 19558494
[TBL] [Abstract][Full Text] [Related]
14. Relationship between lipoxygenase and human testicular cancer.
Yoshimura R; Matsuyama M; Mitsuhashi M; Takemoto Y; Tsuchida K; Kawahito Y; Sano H; Nakatani T
Int J Mol Med; 2004 Mar; 13(3):389-93. PubMed ID: 14767568
[TBL] [Abstract][Full Text] [Related]
15. Effect of vicanicin and protolichesterinic acid on human prostate cancer cells: role of Hsp70 protein.
Russo A; Caggia S; Piovano M; Garbarino J; Cardile V
Chem Biol Interact; 2012 Jan; 195(1):1-10. PubMed ID: 22063921
[TBL] [Abstract][Full Text] [Related]
16. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
[TBL] [Abstract][Full Text] [Related]
17. Protolichesterinic acid enhances doxorubicin-induced apoptosis in HeLa cells in vitro.
Brisdelli F; Perilli M; Sellitri D; Bellio P; Bozzi A; Amicosante G; Nicoletti M; Piovano M; Celenza G
Life Sci; 2016 Aug; 158():89-97. PubMed ID: 27363900
[TBL] [Abstract][Full Text] [Related]
18. Involvement of 5-lipoxygenase in survival of Epstein-Barr virus (EBV)-converted B lymphoma cells.
Belfiore MC; Natoni A; Barzellotti R; Merendino N; Pessina G; Ghibelli L; Gualandi G
Cancer Lett; 2007 Sep; 254(2):236-43. PubMed ID: 17467166
[TBL] [Abstract][Full Text] [Related]
19. Human 5-, 12- and 15-lipoxygenase-1 coexist in kidney but show opposite trends and their balance changes in cancer.
Gohara A; Eltaki N; Sabry D; Murtagh D; Jankun J; Selman SH; Skrzypczak-Jankun E
Oncol Rep; 2012 Oct; 28(4):1275-82. PubMed ID: 22825379
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells.
Zhou GX; Ding XL; Wu SB; Zhang HF; Cao W; Qu LS; Zhang H
Oncol Rep; 2015 Feb; 33(2):661-8. PubMed ID: 25483364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
